Nephrotic Syndrome MedDRA version: 9.1 Level: LLT Classification code 10029164 Term: Nephrotic syndrome
Conditions
Sponsors
ISTITUTO GIANNINA GASLINI
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Age between 1-16 years 2-clinical picture of idiopathic nephrotic syndrome Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Positicity of autoantibodies and low levels of C3
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: To define efficacy of antiCD20 antibodies to mantain remission in patients with nephrotic syndrome dependent to conventional drugs;Secondary Objective: To induce and mantain remission of proteinuria in children with nephrotic syndrome dependent to steroids and cyclosporin;Primary end point(s): To define efficacy of antiCD20 antibodies to mantain remission in patients with nephrotic syndrome dependent to conventional drugs | — |
Countries
Italy
Outcome results
None listed